Andrew Avins to Plant Extracts
This is a "connection" page, showing publications Andrew Avins has written about Plant Extracts.
Connection Strength
2.081
-
Safety and toxicity of saw palmetto in the CAMUS trial. J Urol. 2013 Apr; 189(4):1415-20.
Score: 0.425
-
What do I tell patients about saw palmetto for benign prostatic hyperplasia? Urol Clin North Am. 2011 Aug; 38(3):261-77.
Score: 0.391
-
A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008 Jun; 16(3):147-54.
Score: 0.308
-
Saw palmetto and lower urinary tract symptoms: what is the latest evidence? Curr Urol Rep. 2006 Jul; 7(4):260-5.
Score: 0.275
-
Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 09; 354(6):557-66.
Score: 0.268
-
Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study. Contemp Clin Trials. 2005 Jun; 26(3):397-401.
Score: 0.252
-
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011 Sep 28; 306(12):1344-51.
Score: 0.099
-
An herb for every illness? Am J Med. 1999 Feb; 106(2):259-60.
Score: 0.041
-
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials. 2009 Dec; 6(6):628-36.
Score: 0.022